

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | striatum development (GO:0021756) | 7.41567171 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.08583459 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.08583459 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.80628786 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.77638398 |
| 6 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 6.49470997 |
| 7 | behavioral response to nicotine (GO:0035095) | 5.92880401 |
| 8 | outflow tract septum morphogenesis (GO:0003148) | 5.79904507 |
| 9 | platelet dense granule organization (GO:0060155) | 5.72965998 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.36920565 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.20263595 |
| 12 | neuronal action potential (GO:0019228) | 5.12939093 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.08436431 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 5.05901362 |
| 15 | thrombin receptor signaling pathway (GO:0070493) | 4.96780161 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91729529 |
| 17 | serotonin metabolic process (GO:0042428) | 4.83272499 |
| 18 | glandular epithelial cell development (GO:0002068) | 4.79390054 |
| 19 | positive thymic T cell selection (GO:0045059) | 4.59936782 |
| 20 | leukocyte aggregation (GO:0070486) | 4.57306161 |
| 21 | positive regulation of action potential (GO:0045760) | 4.56541841 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 4.42968468 |
| 23 | embryonic digestive tract development (GO:0048566) | 4.31763384 |
| 24 | primary amino compound metabolic process (GO:1901160) | 4.25853769 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25470940 |
| 26 | negative regulation of cell killing (GO:0031342) | 4.25470940 |
| 27 | positive regulation of fatty acid transport (GO:2000193) | 4.22377767 |
| 28 | negative T cell selection (GO:0043383) | 4.21864638 |
| 29 | cysteine metabolic process (GO:0006534) | 4.19978620 |
| 30 | T cell migration (GO:0072678) | 4.17898936 |
| 31 | negative thymic T cell selection (GO:0045060) | 4.16412266 |
| 32 | negative regulation of chondrocyte differentiation (GO:0032331) | 4.10143981 |
| 33 | positive regulation of prostaglandin secretion (GO:0032308) | 4.07967144 |
| 34 | glomerular filtration (GO:0003094) | 4.03758271 |
| 35 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.03600059 |
| 36 | cellular response to zinc ion (GO:0071294) | 4.02155826 |
| 37 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.95086622 |
| 38 | fucose catabolic process (GO:0019317) | 3.94928360 |
| 39 | L-fucose metabolic process (GO:0042354) | 3.94928360 |
| 40 | L-fucose catabolic process (GO:0042355) | 3.94928360 |
| 41 | response to type I interferon (GO:0034340) | 3.94305223 |
| 42 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.91198400 |
| 43 | cellular response to ATP (GO:0071318) | 3.89362500 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.86722635 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.86722635 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86272880 |
| 47 | positive regulation of icosanoid secretion (GO:0032305) | 3.84025713 |
| 48 | positive T cell selection (GO:0043368) | 3.81976019 |
| 49 | proline transport (GO:0015824) | 3.79924735 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.79071990 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.75714346 |
| 52 | glycine transport (GO:0015816) | 3.75318915 |
| 53 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.70676466 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.69362186 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.67679362 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 3.67589030 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 3.67589030 |
| 58 | tryptophan catabolic process (GO:0006569) | 3.67589030 |
| 59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.64972270 |
| 60 | indole-containing compound metabolic process (GO:0042430) | 3.64051268 |
| 61 | thymic T cell selection (GO:0045061) | 3.63850566 |
| 62 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60629385 |
| 63 | quinone biosynthetic process (GO:1901663) | 3.60618184 |
| 64 | retinoic acid receptor signaling pathway (GO:0048384) | 3.58826113 |
| 65 | negative regulation of telomere maintenance (GO:0032205) | 3.57870197 |
| 66 | T cell selection (GO:0045058) | 3.55179125 |
| 67 | intestinal absorption (GO:0050892) | 3.54842563 |
| 68 | negative regulation of phagocytosis (GO:0050765) | 3.54050933 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 3.53039575 |
| 70 | kynurenine metabolic process (GO:0070189) | 3.52642331 |
| 71 | regulation of systemic arterial blood pressure (GO:0003073) | 3.51654330 |
| 72 | regulation of guanylate cyclase activity (GO:0031282) | 3.48601682 |
| 73 | response to interleukin-15 (GO:0070672) | 3.48552491 |
| 74 | interferon-gamma production (GO:0032609) | 3.47054793 |
| 75 | renal filtration (GO:0097205) | 3.46628691 |
| 76 | reflex (GO:0060004) | 3.46402027 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.46321377 |
| 78 | leukocyte cell-cell adhesion (GO:0007159) | 3.43229197 |
| 79 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.43106940 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 3.41000403 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40527772 |
| 82 | respiratory burst (GO:0045730) | 3.39293277 |
| 83 | mature B cell differentiation (GO:0002335) | 3.34664531 |
| 84 | alanine transport (GO:0032328) | 3.33303989 |
| 85 | glomerulus development (GO:0032835) | 3.32961058 |
| 86 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.32469910 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.32338008 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31703149 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31703149 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 3.31703149 |
| 91 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31703149 |
| 92 | modulation by symbiont of host defense response (GO:0052031) | 3.31703149 |
| 93 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31703149 |
| 94 | angiotensin maturation (GO:0002003) | 3.30439161 |
| 95 | regulation of response to interferon-gamma (GO:0060330) | 3.27997998 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.27050323 |
| 97 | cardiac muscle cell differentiation (GO:0055007) | 3.25329223 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.25133762 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 3.22358236 |
| 100 | regulation of prostaglandin secretion (GO:0032306) | 3.22003303 |
| 101 | mast cell activation (GO:0045576) | 3.21788460 |
| 102 | regulation of cGMP biosynthetic process (GO:0030826) | 3.21117510 |
| 103 | T cell costimulation (GO:0031295) | 3.19935130 |
| 104 | indolalkylamine metabolic process (GO:0006586) | 3.18261493 |
| 105 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.17594505 |
| 106 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.17020462 |
| 107 | cellular response to interleukin-15 (GO:0071350) | 3.16555238 |
| 108 | lymphocyte costimulation (GO:0031294) | 3.14493415 |
| 109 | regulation of action potential (GO:0098900) | 3.13506938 |
| 110 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.12116136 |
| 111 | protein import into peroxisome matrix (GO:0016558) | 3.12044999 |
| 112 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.11407916 |
| 113 | regulation of gene silencing by miRNA (GO:0060964) | 3.11407916 |
| 114 | regulation of gene silencing by RNA (GO:0060966) | 3.11407916 |
| 115 | defense response to protozoan (GO:0042832) | 3.09622603 |
| 116 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09618779 |
| 117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09484638 |
| 118 | NIK/NF-kappaB signaling (GO:0038061) | 3.08828719 |
| 119 | somite development (GO:0061053) | 3.08623869 |
| 120 | negative regulation of cartilage development (GO:0061037) | 3.07440061 |
| 121 | cellular extravasation (GO:0045123) | 3.06277628 |
| 122 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06252370 |
| 123 | response to protozoan (GO:0001562) | 3.04377379 |
| 124 | neutrophil activation involved in immune response (GO:0002283) | 3.04257461 |
| 125 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.03751881 |
| 126 | tryptophan metabolic process (GO:0006568) | 3.02121492 |
| 127 | behavioral response to ethanol (GO:0048149) | 3.01938670 |
| 128 | sulfation (GO:0051923) | 3.00673302 |
| 129 | negative regulation of heart rate (GO:0010459) | 3.00231177 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 3.00056914 |
| 131 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.99292618 |
| 132 | positive regulation of protein kinase C signaling (GO:0090037) | 2.96456276 |
| 133 | ureteric bud development (GO:0001657) | 2.94627992 |
| 134 | exogenous drug catabolic process (GO:0042738) | 2.93861506 |
| 135 | T cell homeostasis (GO:0043029) | 2.93182524 |
| 136 | kidney morphogenesis (GO:0060993) | 2.92616763 |
| 137 | intestinal cholesterol absorption (GO:0030299) | 2.92173973 |
| 138 | myeloid dendritic cell activation (GO:0001773) | 2.91324500 |
| 139 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.91248575 |
| 140 | nephron epithelium morphogenesis (GO:0072088) | 2.91015827 |
| 141 | nephron tubule morphogenesis (GO:0072078) | 2.91015827 |
| 142 | regulation of hippo signaling (GO:0035330) | 2.90877730 |
| 143 | neutrophil mediated immunity (GO:0002446) | 2.90622641 |
| 144 | cellular response to interferon-beta (GO:0035458) | 2.90317409 |
| 145 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.89917142 |
| 146 | regulation of cGMP metabolic process (GO:0030823) | 2.89561002 |
| 147 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88032067 |
| 148 | action potential (GO:0001508) | 2.87281465 |
| 149 | mature B cell differentiation involved in immune response (GO:0002313) | 2.87113710 |
| 150 | central nervous system myelination (GO:0022010) | 2.86792668 |
| 151 | axon ensheathment in central nervous system (GO:0032291) | 2.86792668 |
| 152 | postsynaptic membrane organization (GO:0001941) | 2.86792261 |
| 153 | positive regulation of interleukin-2 production (GO:0032743) | 2.86636932 |
| 154 | ubiquinone biosynthetic process (GO:0006744) | 2.86609786 |
| 155 | lymphocyte homeostasis (GO:0002260) | 2.84805864 |
| 156 | cGMP-mediated signaling (GO:0019934) | 2.84706170 |
| 157 | positive regulation of lamellipodium assembly (GO:0010592) | 2.84252377 |
| 158 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.83727837 |
| 159 | regulation of icosanoid secretion (GO:0032303) | 2.82836976 |
| 160 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.82442468 |
| 161 | startle response (GO:0001964) | 2.80264378 |
| 162 | gamma-aminobutyric acid transport (GO:0015812) | 2.78695137 |
| 163 | regulation of myelination (GO:0031641) | 2.78559602 |
| 164 | tolerance induction (GO:0002507) | 2.78417985 |
| 165 | negative regulation of interleukin-12 production (GO:0032695) | 2.78103021 |
| 166 | drug catabolic process (GO:0042737) | 2.77701646 |
| 167 | epithelial cilium movement (GO:0003351) | 2.77386372 |
| 168 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.76993654 |
| 169 | neuronal stem cell maintenance (GO:0097150) | 2.76592909 |
| 170 | positive regulation of organic acid transport (GO:0032892) | 2.76399412 |
| 171 | hepatocyte apoptotic process (GO:0097284) | 2.75627083 |
| 172 | macrophage activation involved in immune response (GO:0002281) | 2.75150711 |
| 173 | positive regulation of interferon-beta production (GO:0032728) | 2.73936675 |
| 174 | B cell homeostasis (GO:0001782) | 2.73831603 |
| 175 | neutrophil activation (GO:0042119) | 2.73322343 |
| 176 | B cell mediated immunity (GO:0019724) | 2.72708718 |
| 177 | cellular response to interferon-gamma (GO:0071346) | 2.72193052 |
| 178 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.71562345 |
| 179 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.71012646 |
| 180 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.69863769 |
| 181 | ubiquinone metabolic process (GO:0006743) | 2.69599734 |
| 182 | activated T cell proliferation (GO:0050798) | 2.69036168 |
| 183 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68029596 |
| 184 | epoxygenase P450 pathway (GO:0019373) | 2.67948525 |
| 185 | positive regulation of isotype switching (GO:0045830) | 2.67684471 |
| 186 | myeloid cell activation involved in immune response (GO:0002275) | 2.67308174 |
| 187 | response to fungus (GO:0009620) | 2.67278563 |
| 188 | T cell proliferation (GO:0042098) | 2.67192492 |
| 189 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.66811973 |
| 190 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.66811973 |
| 191 | endocrine process (GO:0050886) | 2.66811973 |
| 192 | germinal center formation (GO:0002467) | 2.66704711 |
| 193 | neuron fate determination (GO:0048664) | 2.65673981 |
| 194 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.65205329 |
| 195 | regulation of antigen processing and presentation (GO:0002577) | 2.64659355 |
| 196 | regulation of tolerance induction (GO:0002643) | 2.63870357 |
| 197 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.63749863 |
| 198 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.63749863 |
| 199 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.63749863 |
| 200 | mesonephric tubule development (GO:0072164) | 2.62434073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 5.72218890 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55642161 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.69966432 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30857234 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.07467667 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.98249288 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.80889226 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.74727248 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.60511426 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.54906434 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.53592884 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.24938855 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.17945786 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.01254059 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00574546 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98190538 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.91812919 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86553762 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.82919730 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.78798293 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74619706 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71472439 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.70260576 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.67134065 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.64745014 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61027849 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.51623012 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48984451 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.44582412 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42464005 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32755304 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.31607673 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31460195 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29641795 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.27629483 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.26126676 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.19239726 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11384530 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09591681 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.08852023 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06642540 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.01412616 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00962679 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98641099 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96408027 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95782173 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95607441 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.94881764 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92584838 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92145206 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86024342 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81932281 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74441739 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73441957 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71653904 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70560824 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69234920 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68140577 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67722273 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66115289 |
| 61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.66097819 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65451121 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59181204 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58594824 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58229351 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.57790633 |
| 67 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57076815 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56855441 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56533792 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55898182 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.55184810 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.50359269 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48565678 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47755612 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47358518 |
| 76 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46426494 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45710541 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45078178 |
| 79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44988679 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44787955 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.44606937 |
| 82 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43916737 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43682671 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43395583 |
| 85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41632987 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40348759 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.39299154 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38041588 |
| 89 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.36746650 |
| 90 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36687421 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36625728 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36143175 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34724642 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34334477 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33280581 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32872824 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32610928 |
| 98 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31945305 |
| 99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31369889 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29485671 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.29219221 |
| 102 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.29029214 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27360679 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27263493 |
| 105 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26733970 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26509618 |
| 107 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.24573547 |
| 108 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.24573547 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.23946828 |
| 110 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23905690 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23235826 |
| 112 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22770626 |
| 113 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22560685 |
| 114 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.20206618 |
| 115 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19434675 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19409330 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19215975 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17842232 |
| 119 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17304357 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16650963 |
| 121 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16422821 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15991031 |
| 123 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15939983 |
| 124 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15813565 |
| 125 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15390252 |
| 126 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15232129 |
| 127 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15158561 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14943698 |
| 129 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14887389 |
| 130 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14768311 |
| 131 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.14708446 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14323708 |
| 133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13448293 |
| 134 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13420634 |
| 135 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13325755 |
| 136 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13254104 |
| 137 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12435148 |
| 138 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11956622 |
| 139 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11945931 |
| 140 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11712910 |
| 141 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10976855 |
| 142 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10753353 |
| 143 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10604218 |
| 144 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09908501 |
| 145 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09694666 |
| 146 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09285827 |
| 147 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08892801 |
| 148 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08857263 |
| 149 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.08627244 |
| 150 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07993683 |
| 151 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07701616 |
| 152 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07658480 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07475468 |
| 154 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06930760 |
| 155 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06930760 |
| 156 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05940547 |
| 157 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05872840 |
| 158 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05715932 |
| 159 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04462222 |
| 160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04462222 |
| 161 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02964418 |
| 162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02845054 |
| 163 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02317355 |
| 164 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01185402 |
| 165 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01056463 |
| 166 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00792004 |
| 167 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00694506 |
| 168 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00305039 |
| 169 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00107927 |
| 170 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99640050 |
| 171 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99476094 |
| 172 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97469925 |
| 173 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96998770 |
| 174 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96986167 |
| 175 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96709390 |
| 176 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96709390 |
| 177 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.96676289 |
| 178 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92319581 |
| 179 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88111496 |
| 180 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83723310 |
| 181 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.83397530 |
| 182 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82677256 |
| 183 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81885853 |
| 184 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80234701 |
| 185 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79457485 |
| 186 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79438959 |
| 187 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78383138 |
| 188 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77106399 |
| 189 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76025426 |
| 190 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75016980 |
| 191 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73374209 |
| 192 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.72561074 |
| 193 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72225386 |
| 194 | P300_27268052_Chip-Seq_Bcells_Human | 0.72097887 |
| 195 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71183103 |
| 196 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.71175723 |
| 197 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70771911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010030_abnormal_orbit_morphology | 7.33544224 |
| 2 | MP0005248_abnormal_Harderian_gland | 5.11634116 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.99500283 |
| 4 | MP0003136_yellow_coat_color | 3.65878752 |
| 5 | MP0003880_abnormal_central_pattern | 3.25460640 |
| 6 | MP0001800_abnormal_humoral_immune | 3.23555682 |
| 7 | MP0005671_abnormal_response_to | 3.22833769 |
| 8 | MP0005387_immune_system_phenotype | 3.21238863 |
| 9 | MP0001790_abnormal_immune_system | 3.21238863 |
| 10 | MP0000685_abnormal_immune_system | 3.19350388 |
| 11 | MP0003763_abnormal_thymus_physiology | 3.14757664 |
| 12 | MP0009785_altered_susceptibility_to | 3.04199858 |
| 13 | MP0003303_peritoneal_inflammation | 2.93054317 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.92342397 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.85798034 |
| 16 | MP0003436_decreased_susceptibility_to | 2.78527349 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.78490071 |
| 18 | MP0004885_abnormal_endolymph | 2.76159514 |
| 19 | MP0005025_abnormal_response_to | 2.75141432 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.70604268 |
| 21 | MP0001819_abnormal_immune_cell | 2.67463157 |
| 22 | MP0002249_abnormal_larynx_morphology | 2.67017184 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.66820935 |
| 24 | MP0002723_abnormal_immune_serum | 2.63280489 |
| 25 | MP0003724_increased_susceptibility_to | 2.59737148 |
| 26 | MP0002419_abnormal_innate_immunity | 2.51131519 |
| 27 | MP0002282_abnormal_trachea_morphology | 2.50364978 |
| 28 | MP0002398_abnormal_bone_marrow | 2.42106131 |
| 29 | MP0002166_altered_tumor_susceptibility | 2.34243091 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.26391796 |
| 31 | MP0003300_gastrointestinal_ulcer | 2.23371580 |
| 32 | MP0000716_abnormal_immune_system | 2.22391501 |
| 33 | MP0003183_abnormal_peptide_metabolism | 2.20020732 |
| 34 | MP0010155_abnormal_intestine_physiology | 2.16251198 |
| 35 | MP0003283_abnormal_digestive_organ | 2.11638525 |
| 36 | MP0005365_abnormal_bile_salt | 2.07939385 |
| 37 | MP0002405_respiratory_system_inflammati | 2.03682403 |
| 38 | MP0005464_abnormal_platelet_physiology | 2.03554723 |
| 39 | MP0000534_abnormal_ureter_morphology | 2.03356490 |
| 40 | MP0000613_abnormal_salivary_gland | 2.01659052 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 2.01605365 |
| 42 | MP0000689_abnormal_spleen_morphology | 2.01511332 |
| 43 | MP0004947_skin_inflammation | 1.98229748 |
| 44 | MP0003011_delayed_dark_adaptation | 1.96481155 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.95846700 |
| 46 | MP0005085_abnormal_gallbladder_physiolo | 1.91629876 |
| 47 | MP0002722_abnormal_immune_system | 1.91349817 |
| 48 | MP0001873_stomach_inflammation | 1.89716813 |
| 49 | MP0002429_abnormal_blood_cell | 1.85955021 |
| 50 | MP0003195_calcinosis | 1.85367288 |
| 51 | MP0003866_abnormal_defecation | 1.83132199 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.80907735 |
| 53 | MP0005171_absent_coat_pigmentation | 1.76622900 |
| 54 | MP0002006_tumorigenesis | 1.74864719 |
| 55 | MP0001853_heart_inflammation | 1.72398607 |
| 56 | MP0004742_abnormal_vestibular_system | 1.69927710 |
| 57 | MP0001485_abnormal_pinna_reflex | 1.65399236 |
| 58 | MP0006082_CNS_inflammation | 1.65014657 |
| 59 | MP0001984_abnormal_olfaction | 1.62950112 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.62185492 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.61708208 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.59044035 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.57370357 |
| 64 | MP0004510_myositis | 1.56914563 |
| 65 | MP0005083_abnormal_biliary_tract | 1.54043791 |
| 66 | MP0005360_urolithiasis | 1.51034402 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.49128779 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.49128779 |
| 69 | MP0002102_abnormal_ear_morphology | 1.48176513 |
| 70 | MP0002932_abnormal_joint_morphology | 1.44536280 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.43167091 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 1.42531418 |
| 73 | MP0001188_hyperpigmentation | 1.39640487 |
| 74 | MP0009278_abnormal_bone_marrow | 1.38478324 |
| 75 | MP0008469_abnormal_protein_level | 1.37529127 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.36851275 |
| 77 | MP0000230_abnormal_systemic_arterial | 1.35736092 |
| 78 | MP0009745_abnormal_behavioral_response | 1.34385015 |
| 79 | MP0000490_abnormal_crypts_of | 1.32031335 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.31574595 |
| 81 | MP0000858_altered_metastatic_potential | 1.31192683 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.30725147 |
| 83 | MP0001664_abnormal_digestion | 1.30723284 |
| 84 | MP0002933_joint_inflammation | 1.29963365 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 1.29720381 |
| 86 | MP0003448_altered_tumor_morphology | 1.28826066 |
| 87 | MP0005174_abnormal_tail_pigmentation | 1.28075582 |
| 88 | MP0010329_abnormal_lipoprotein_level | 1.27909328 |
| 89 | MP0001968_abnormal_touch/_nociception | 1.25842230 |
| 90 | MP0005197_abnormal_uvea_morphology | 1.24799584 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.21845800 |
| 92 | MP0005595_abnormal_vascular_smooth | 1.21626770 |
| 93 | MP0008872_abnormal_physiological_respon | 1.20354652 |
| 94 | MP0000427_abnormal_hair_cycle | 1.19887089 |
| 95 | MP0009840_abnormal_foam_cell | 1.19191182 |
| 96 | MP0000778_abnormal_nervous_system | 1.18836107 |
| 97 | MP0002909_abnormal_adrenal_gland | 1.17667870 |
| 98 | MP0002736_abnormal_nociception_after | 1.17228056 |
| 99 | MP0003172_abnormal_lysosome_physiology | 1.16198703 |
| 100 | MP0004133_heterotaxia | 1.15038936 |
| 101 | MP0003718_maternal_effect | 1.13595954 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 1.13276869 |
| 103 | MP0004142_abnormal_muscle_tone | 1.13238673 |
| 104 | MP0002751_abnormal_autonomic_nervous | 1.11961148 |
| 105 | MP0002272_abnormal_nervous_system | 1.11956423 |
| 106 | MP0000538_abnormal_urinary_bladder | 1.11949756 |
| 107 | MP0000343_altered_response_to | 1.11408141 |
| 108 | MP0005332_abnormal_amino_acid | 1.10750774 |
| 109 | MP0001986_abnormal_taste_sensitivity | 1.10116947 |
| 110 | MP0003191_abnormal_cellular_cholesterol | 1.03052003 |
| 111 | MP0004043_abnormal_pH_regulation | 1.01553064 |
| 112 | MP0003329_amyloid_beta_deposits | 1.01305029 |
| 113 | MP0005448_abnormal_energy_balance | 1.00892698 |
| 114 | MP0005310_abnormal_salivary_gland | 1.00650989 |
| 115 | MP0002064_seizures | 1.00436750 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.94274071 |
| 117 | MP0003635_abnormal_synaptic_transmissio | 0.94114274 |
| 118 | MP0001486_abnormal_startle_reflex | 0.93792358 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.93233002 |
| 120 | MP0002019_abnormal_tumor_incidence | 0.92187864 |
| 121 | MP0002063_abnormal_learning/memory/cond | 0.91992577 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.91984007 |
| 123 | MP0002067_abnormal_sensory_capabilities | 0.90983070 |
| 124 | MP0000026_abnormal_inner_ear | 0.90763857 |
| 125 | MP0005253_abnormal_eye_physiology | 0.90457757 |
| 126 | MP0003959_abnormal_lean_body | 0.89724162 |
| 127 | MP0001286_abnormal_eye_development | 0.88714340 |
| 128 | MP0003828_pulmonary_edema | 0.88496058 |
| 129 | MP0002572_abnormal_emotion/affect_behav | 0.87828922 |
| 130 | MP0001663_abnormal_digestive_system | 0.87653139 |
| 131 | MP0003632_abnormal_nervous_system | 0.87530723 |
| 132 | MP0006054_spinal_hemorrhage | 0.86349945 |
| 133 | MP0010307_abnormal_tumor_latency | 0.86297281 |
| 134 | MP0009764_decreased_sensitivity_to | 0.85918869 |
| 135 | MP0006276_abnormal_autonomic_nervous | 0.85567517 |
| 136 | MP0009763_increased_sensitivity_to | 0.85427440 |
| 137 | MP0003693_abnormal_embryo_hatching | 0.85296092 |
| 138 | MP0002233_abnormal_nose_morphology | 0.84463189 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.83892915 |
| 140 | MP0000015_abnormal_ear_pigmentation | 0.83756915 |
| 141 | MP0008775_abnormal_heart_ventricle | 0.83723648 |
| 142 | MP0000604_amyloidosis | 0.83245571 |
| 143 | MP0002277_abnormal_respiratory_mucosa | 0.82805353 |
| 144 | MP0001851_eye_inflammation | 0.82641513 |
| 145 | MP0001970_abnormal_pain_threshold | 0.82553520 |
| 146 | MP0005023_abnormal_wound_healing | 0.82425401 |
| 147 | MP0002733_abnormal_thermal_nociception | 0.81903552 |
| 148 | MP0000249_abnormal_blood_vessel | 0.81819210 |
| 149 | MP0005195_abnormal_posterior_eye | 0.81580620 |
| 150 | MP0002234_abnormal_pharynx_morphology | 0.80015275 |
| 151 | MP0004145_abnormal_muscle_electrophysio | 0.78377753 |
| 152 | MP0000647_abnormal_sebaceous_gland | 0.77062656 |
| 153 | MP0009046_muscle_twitch | 0.76892403 |
| 154 | MP0002734_abnormal_mechanical_nocicepti | 0.76087257 |
| 155 | MP0002139_abnormal_hepatobiliary_system | 0.76032216 |
| 156 | MP0000383_abnormal_hair_follicle | 0.75605292 |
| 157 | MP0000609_abnormal_liver_physiology | 0.74647809 |
| 158 | MP0003656_abnormal_erythrocyte_physiolo | 0.74543895 |
| 159 | MP0003646_muscle_fatigue | 0.74028551 |
| 160 | MP0002998_abnormal_bone_remodeling | 0.74021427 |
| 161 | MP0008877_abnormal_DNA_methylation | 0.73033661 |
| 162 | MP0005166_decreased_susceptibility_to | 0.72352856 |
| 163 | MP0002557_abnormal_social/conspecific_i | 0.72172557 |
| 164 | MP0005381_digestive/alimentary_phenotyp | 0.70908375 |
| 165 | MP0001324_abnormal_eye_pigmentation | 0.69810948 |
| 166 | MP0002752_abnormal_somatic_nervous | 0.69684164 |
| 167 | MP0005508_abnormal_skeleton_morphology | 0.69405820 |
| 168 | MP0006072_abnormal_retinal_apoptosis | 0.69316752 |
| 169 | MP0010386_abnormal_urinary_bladder | 0.69262958 |
| 170 | MP0000049_abnormal_middle_ear | 0.67850596 |
| 171 | MP0002136_abnormal_kidney_physiology | 0.67543655 |
| 172 | MP0003566_abnormal_cell_adhesion | 0.66393057 |
| 173 | MP0003045_fibrosis | 0.64934187 |
| 174 | MP0003075_altered_response_to | 0.64291588 |
| 175 | MP0005075_abnormal_melanosome_morpholog | 0.64254723 |
| 176 | MP0005076_abnormal_cell_differentiation | 0.63078272 |
| 177 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62062429 |
| 178 | MP0000477_abnormal_intestine_morphology | 0.59907028 |
| 179 | MP0000569_abnormal_digit_pigmentation | 0.59005117 |
| 180 | MP0002095_abnormal_skin_pigmentation | 0.58075735 |
| 181 | MP0008057_abnormal_DNA_replication | 0.57152407 |
| 182 | MP0003077_abnormal_cell_cycle | 0.55009481 |
| 183 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53106226 |
| 184 | MP0003091_abnormal_cell_migration | 0.52813904 |
| 185 | MP0000598_abnormal_liver_morphology | 0.52591254 |
| 186 | MP0003950_abnormal_plasma_membrane | 0.52190029 |
| 187 | MP0009643_abnormal_urine_homeostasis | 0.51811918 |
| 188 | MP0005390_skeleton_phenotype | 0.51192790 |
| 189 | MP0008873_increased_physiological_sensi | 0.50084029 |
| 190 | MP0009765_abnormal_xenobiotic_induced | 0.49267167 |
| 191 | MP0004147_increased_porphyrin_level | 0.49135140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal pancreas size (HP:0012094) | 8.55372790 |
| 2 | Annular pancreas (HP:0001734) | 7.52704319 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.16582476 |
| 4 | Anophthalmia (HP:0000528) | 5.13012731 |
| 5 | Bicornuate uterus (HP:0000813) | 5.11343925 |
| 6 | Recurrent viral infections (HP:0004429) | 4.95910234 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.80941762 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.51823154 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.51543072 |
| 10 | Hydroxyprolinuria (HP:0003080) | 4.46458508 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 4.46458508 |
| 12 | Chronic otitis media (HP:0000389) | 4.41110370 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.40259260 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.32961506 |
| 15 | Congenital sensorineural hearing impairment (HP:0008527) | 4.32536610 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31319840 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.27829640 |
| 18 | Pancreatic cysts (HP:0001737) | 4.22248592 |
| 19 | Abnormality of B cell number (HP:0010975) | 4.18850311 |
| 20 | B lymphocytopenia (HP:0010976) | 4.18850311 |
| 21 | IgM deficiency (HP:0002850) | 4.01974589 |
| 22 | T lymphocytopenia (HP:0005403) | 3.99965712 |
| 23 | Stomatitis (HP:0010280) | 3.96852319 |
| 24 | Myositis (HP:0100614) | 3.93700938 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.87569317 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.86988182 |
| 27 | Eosinophilia (HP:0001880) | 3.76312801 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.74893049 |
| 29 | Abnormal lung lobation (HP:0002101) | 3.67747573 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 3.64972882 |
| 31 | Abnormality of T cells (HP:0002843) | 3.64553942 |
| 32 | Pustule (HP:0200039) | 3.61871722 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.60370089 |
| 34 | Thyroiditis (HP:0100646) | 3.58066739 |
| 35 | Hyperglycinuria (HP:0003108) | 3.55380973 |
| 36 | Lymphopenia (HP:0001888) | 3.55100652 |
| 37 | Meningitis (HP:0001287) | 3.49230208 |
| 38 | Nasal polyposis (HP:0100582) | 3.49107912 |
| 39 | Abnormality of midbrain morphology (HP:0002418) | 3.45776430 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 3.45776430 |
| 41 | Gastrointestinal stroma tumor (HP:0100723) | 3.45261763 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 3.45005439 |
| 43 | Combined immunodeficiency (HP:0005387) | 3.43300481 |
| 44 | Type II lissencephaly (HP:0007260) | 3.43218747 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.43003300 |
| 46 | Thrombocytosis (HP:0001894) | 3.40481551 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 3.38142427 |
| 48 | Vasculitis (HP:0002633) | 3.37571582 |
| 49 | Cellulitis (HP:0100658) | 3.34838824 |
| 50 | Increased IgE level (HP:0003212) | 3.33130828 |
| 51 | Tubular atrophy (HP:0000092) | 3.32691130 |
| 52 | Granulocytopenia (HP:0001913) | 3.31304871 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 3.27978016 |
| 54 | Abnormality of eosinophils (HP:0001879) | 3.27178756 |
| 55 | Epidermoid cyst (HP:0200040) | 3.25968335 |
| 56 | Inflammation of the large intestine (HP:0002037) | 3.25173580 |
| 57 | True hermaphroditism (HP:0010459) | 3.23286879 |
| 58 | Chronic diarrhea (HP:0002028) | 3.23214522 |
| 59 | Large for gestational age (HP:0001520) | 3.22801108 |
| 60 | Confusion (HP:0001289) | 3.22282128 |
| 61 | Recurrent skin infections (HP:0001581) | 3.21248801 |
| 62 | Congenital stationary night blindness (HP:0007642) | 3.19609279 |
| 63 | Obstructive lung disease (HP:0006536) | 3.19384248 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19384248 |
| 65 | Pancreatic fibrosis (HP:0100732) | 3.18739929 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 3.16329319 |
| 67 | Colitis (HP:0002583) | 3.14001037 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 3.13494133 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13183988 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13183988 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 3.11637312 |
| 72 | Gingivitis (HP:0000230) | 3.04690172 |
| 73 | Leukocytosis (HP:0001974) | 3.04467381 |
| 74 | Decreased circulating renin level (HP:0003351) | 3.02915117 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.99871256 |
| 76 | Periodontitis (HP:0000704) | 2.93213150 |
| 77 | Nephronophthisis (HP:0000090) | 2.92898395 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85889440 |
| 79 | Metabolic alkalosis (HP:0200114) | 2.84517735 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 2.84100795 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 2.82958411 |
| 82 | Hyperalaninemia (HP:0003348) | 2.82958411 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.82958411 |
| 84 | IgG deficiency (HP:0004315) | 2.82044135 |
| 85 | Recurrent sinusitis (HP:0011108) | 2.81441245 |
| 86 | Duodenal stenosis (HP:0100867) | 2.79550763 |
| 87 | Small intestinal stenosis (HP:0012848) | 2.79550763 |
| 88 | IgA deficiency (HP:0002720) | 2.75448247 |
| 89 | Abnormality of the fingertips (HP:0001211) | 2.74656836 |
| 90 | Inability to walk (HP:0002540) | 2.72617008 |
| 91 | Broad nasal tip (HP:0000455) | 2.67195368 |
| 92 | Chronic sinusitis (HP:0011109) | 2.65469884 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.64716589 |
| 94 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.63878936 |
| 95 | Abnormality of glycine metabolism (HP:0010895) | 2.63878936 |
| 96 | Orchitis (HP:0100796) | 2.63635719 |
| 97 | Encephalitis (HP:0002383) | 2.62794381 |
| 98 | Stomach cancer (HP:0012126) | 2.62593593 |
| 99 | Verrucae (HP:0200043) | 2.62312407 |
| 100 | Papilloma (HP:0012740) | 2.62312407 |
| 101 | Emphysema (HP:0002097) | 2.54293229 |
| 102 | Hypoplasia of the thymus (HP:0000778) | 2.50373161 |
| 103 | Pulmonary infiltrates (HP:0002113) | 2.50367911 |
| 104 | Hyperventilation (HP:0002883) | 2.49907742 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.49866420 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.48058512 |
| 107 | Lymphoma (HP:0002665) | 2.43072429 |
| 108 | Congenital, generalized hypertrichosis (HP:0004540) | 2.41780169 |
| 109 | Chest pain (HP:0100749) | 2.40645501 |
| 110 | Bronchitis (HP:0012387) | 2.40500590 |
| 111 | Osteomyelitis (HP:0002754) | 2.40332826 |
| 112 | Restrictive lung disease (HP:0002091) | 2.39441437 |
| 113 | Retrobulbar optic neuritis (HP:0100654) | 2.39396174 |
| 114 | Optic neuritis (HP:0100653) | 2.39396174 |
| 115 | Abnormal platelet volume (HP:0011876) | 2.37874314 |
| 116 | Sepsis (HP:0100806) | 2.36887328 |
| 117 | Attenuation of retinal blood vessels (HP:0007843) | 2.35538790 |
| 118 | Abnormal drinking behavior (HP:0030082) | 2.35520921 |
| 119 | Polydipsia (HP:0001959) | 2.35520921 |
| 120 | Abnormality of the prostate (HP:0008775) | 2.35469892 |
| 121 | Cystic liver disease (HP:0006706) | 2.34278257 |
| 122 | Skin ulcer (HP:0200042) | 2.29981960 |
| 123 | Prolonged bleeding time (HP:0003010) | 2.29570228 |
| 124 | Xanthomatosis (HP:0000991) | 2.28940171 |
| 125 | Abnormality of the duodenum (HP:0002246) | 2.28896904 |
| 126 | Tubulointerstitial fibrosis (HP:0005576) | 2.25370223 |
| 127 | Petechiae (HP:0000967) | 2.24409355 |
| 128 | Hemoptysis (HP:0002105) | 2.21876174 |
| 129 | Alkalosis (HP:0001948) | 2.18801356 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 2.18573235 |
| 131 | Furrowed tongue (HP:0000221) | 2.18244288 |
| 132 | Progressive inability to walk (HP:0002505) | 2.17279535 |
| 133 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.16438211 |
| 134 | Absent/shortened dynein arms (HP:0200106) | 2.16438211 |
| 135 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.15118373 |
| 136 | Polyuria (HP:0000103) | 2.14401649 |
| 137 | Birth length less than 3rd percentile (HP:0003561) | 2.12537993 |
| 138 | Progressive cerebellar ataxia (HP:0002073) | 2.11619898 |
| 139 | Abnormal urine output (HP:0012590) | 2.11589639 |
| 140 | Abnormality of vitamin B metabolism (HP:0004340) | 2.10846874 |
| 141 | Recurrent pneumonia (HP:0006532) | 2.07378310 |
| 142 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07038574 |
| 143 | Anterior segment dysgenesis (HP:0007700) | 2.06645691 |
| 144 | Polyphagia (HP:0002591) | 2.06055532 |
| 145 | Poikiloderma (HP:0001029) | 2.05967903 |
| 146 | Hemiparesis (HP:0001269) | 2.05201703 |
| 147 | Potter facies (HP:0002009) | 2.04961312 |
| 148 | Facial shape deformation (HP:0011334) | 2.04961312 |
| 149 | Gastrointestinal infarctions (HP:0005244) | 2.04906844 |
| 150 | Epistaxis (HP:0000421) | 2.01966186 |
| 151 | Lissencephaly (HP:0001339) | 2.01829172 |
| 152 | Arterial thrombosis (HP:0004420) | 2.01716978 |
| 153 | Optic nerve hypoplasia (HP:0000609) | 1.98603015 |
| 154 | Increased mean platelet volume (HP:0011877) | 1.97273983 |
| 155 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97212042 |
| 156 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97212042 |
| 157 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97190100 |
| 158 | Impaired platelet aggregation (HP:0003540) | 1.97129451 |
| 159 | Abnormal platelet function (HP:0011869) | 1.97129451 |
| 160 | Bilateral microphthalmos (HP:0007633) | 1.96389318 |
| 161 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.96106523 |
| 162 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.95572286 |
| 163 | Hypoproteinemia (HP:0003075) | 1.95329020 |
| 164 | Skin rash (HP:0000988) | 1.93427715 |
| 165 | Keratoconjunctivitis sicca (HP:0001097) | 1.92846960 |
| 166 | Genetic anticipation (HP:0003743) | 1.91478785 |
| 167 | Urticaria (HP:0001025) | 1.89832552 |
| 168 | Abnormality of renal excretion (HP:0011036) | 1.89443575 |
| 169 | Hematochezia (HP:0002573) | 1.89203398 |
| 170 | Vacuolated lymphocytes (HP:0001922) | 1.89125381 |
| 171 | Hyperaldosteronism (HP:0000859) | 1.88430465 |
| 172 | Sclerocornea (HP:0000647) | 1.86966292 |
| 173 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.85669836 |
| 174 | Retinal dysplasia (HP:0007973) | 1.85551184 |
| 175 | Prominent supraorbital ridges (HP:0000336) | 1.85298679 |
| 176 | Joint swelling (HP:0001386) | 1.84021173 |
| 177 | Abnormal ciliary motility (HP:0012262) | 1.82272572 |
| 178 | Glycosuria (HP:0003076) | 1.77503000 |
| 179 | Abnormality of urine glucose concentration (HP:0011016) | 1.77503000 |
| 180 | Abnormality of the pons (HP:0007361) | 1.76285218 |
| 181 | Hypokalemia (HP:0002900) | 1.76222124 |
| 182 | Spastic tetraparesis (HP:0001285) | 1.75539657 |
| 183 | Mesangial abnormality (HP:0001966) | 1.72997549 |
| 184 | Pulmonary hypoplasia (HP:0002089) | 1.71956466 |
| 185 | Decreased central vision (HP:0007663) | 1.70938853 |
| 186 | Absent speech (HP:0001344) | 1.70541915 |
| 187 | Chorioretinal atrophy (HP:0000533) | 1.70300082 |
| 188 | Hypoplasia of the pons (HP:0012110) | 1.70285525 |
| 189 | Cerebellar dysplasia (HP:0007033) | 1.69182726 |
| 190 | Brushfield spots (HP:0001088) | 1.68816154 |
| 191 | Male pseudohermaphroditism (HP:0000037) | 1.67761739 |
| 192 | Abolished electroretinogram (ERG) (HP:0000550) | 1.65226735 |
| 193 | Patellar aplasia (HP:0006443) | 1.63027792 |
| 194 | Abnormal albumin level (HP:0012116) | 1.62993039 |
| 195 | Hypoalbuminemia (HP:0003073) | 1.62993039 |
| 196 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.59235868 |
| 197 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.58705371 |
| 198 | Anencephaly (HP:0002323) | 1.58484436 |
| 199 | Gait imbalance (HP:0002141) | 1.55585867 |
| 200 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.55475246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.35742690 |
| 2 | PINK1 | 4.75369935 |
| 3 | BMPR1B | 3.51196387 |
| 4 | TXK | 3.47810407 |
| 5 | ADRBK2 | 3.18647072 |
| 6 | TYK2 | 3.12689196 |
| 7 | TLK1 | 2.97170822 |
| 8 | CASK | 2.90180574 |
| 9 | TNIK | 2.88857505 |
| 10 | PNCK | 2.85472759 |
| 11 | CAMKK2 | 2.64071869 |
| 12 | BLK | 2.61555709 |
| 13 | STK10 | 2.60688435 |
| 14 | GRK6 | 2.54927219 |
| 15 | MAPK15 | 2.51333325 |
| 16 | JAK3 | 2.50889109 |
| 17 | ERN1 | 2.32021913 |
| 18 | ZAP70 | 2.31379377 |
| 19 | IKBKE | 2.31263111 |
| 20 | GRK1 | 2.24781807 |
| 21 | IRAK4 | 2.21202778 |
| 22 | TBK1 | 2.20252190 |
| 23 | JAK1 | 2.18679485 |
| 24 | ITK | 2.18634735 |
| 25 | KIT | 2.17378579 |
| 26 | MAP3K14 | 2.10441859 |
| 27 | INSRR | 2.09324418 |
| 28 | BTK | 2.06006175 |
| 29 | TYRO3 | 2.03051956 |
| 30 | WNK4 | 2.00296455 |
| 31 | MAP3K10 | 1.96781745 |
| 32 | TEC | 1.93733082 |
| 33 | MAPK13 | 1.92083503 |
| 34 | SYK | 1.83366933 |
| 35 | WNK3 | 1.80683260 |
| 36 | MST4 | 1.79646842 |
| 37 | FGFR4 | 1.74333759 |
| 38 | CSF1R | 1.68839276 |
| 39 | ZAK | 1.68368210 |
| 40 | CSK | 1.67451730 |
| 41 | MAP3K13 | 1.59439510 |
| 42 | LCK | 1.55129979 |
| 43 | LRRK2 | 1.55087825 |
| 44 | HCK | 1.52838411 |
| 45 | DAPK2 | 1.46018818 |
| 46 | PKN2 | 1.44553359 |
| 47 | PIK3CA | 1.44469694 |
| 48 | MAP3K4 | 1.43509713 |
| 49 | DYRK2 | 1.41068790 |
| 50 | FGFR3 | 1.39436436 |
| 51 | FES | 1.37651490 |
| 52 | RIPK4 | 1.36897101 |
| 53 | MAP4K2 | 1.35188004 |
| 54 | BRSK2 | 1.33689190 |
| 55 | FLT3 | 1.30532908 |
| 56 | TAOK3 | 1.29465151 |
| 57 | IRAK3 | 1.26927394 |
| 58 | EEF2K | 1.23341500 |
| 59 | CAMKK1 | 1.22942653 |
| 60 | MAP2K3 | 1.22172112 |
| 61 | MARK3 | 1.21937038 |
| 62 | OXSR1 | 1.21214950 |
| 63 | KDR | 1.19992709 |
| 64 | MAP2K7 | 1.17524084 |
| 65 | TTN | 1.14848031 |
| 66 | LYN | 1.14527490 |
| 67 | MARK1 | 1.13759406 |
| 68 | IKBKB | 1.12882740 |
| 69 | ADRBK1 | 1.12275341 |
| 70 | PTK2B | 1.08214584 |
| 71 | CLK1 | 1.08211591 |
| 72 | EPHB1 | 1.04977234 |
| 73 | PIM1 | 1.02658375 |
| 74 | TGFBR2 | 1.01323302 |
| 75 | PRKCG | 0.98080154 |
| 76 | NLK | 0.97417015 |
| 77 | VRK1 | 0.95492380 |
| 78 | STK39 | 0.90782416 |
| 79 | JAK2 | 0.89910841 |
| 80 | PRKCQ | 0.82800812 |
| 81 | NTRK2 | 0.82554284 |
| 82 | SIK2 | 0.79746656 |
| 83 | PIK3CG | 0.78981949 |
| 84 | ERBB2 | 0.77320833 |
| 85 | TESK2 | 0.76197032 |
| 86 | WEE1 | 0.75552700 |
| 87 | RPS6KA4 | 0.73795466 |
| 88 | STK4 | 0.73143909 |
| 89 | PIM2 | 0.72935271 |
| 90 | NTRK3 | 0.70746179 |
| 91 | MAP2K4 | 0.70005066 |
| 92 | STK11 | 0.69068641 |
| 93 | ACVR1B | 0.67314101 |
| 94 | EPHB2 | 0.66102708 |
| 95 | TSSK6 | 0.64409265 |
| 96 | DYRK1A | 0.64313155 |
| 97 | DYRK1B | 0.63365984 |
| 98 | PRKCE | 0.62936957 |
| 99 | MAPKAPK5 | 0.62892882 |
| 100 | CHUK | 0.61945699 |
| 101 | IRAK1 | 0.61472120 |
| 102 | NME2 | 0.61262311 |
| 103 | TGFBR1 | 0.60571885 |
| 104 | CDK4 | 0.59576991 |
| 105 | CAMK2A | 0.59393202 |
| 106 | PTK6 | 0.59145016 |
| 107 | TRIB3 | 0.58920867 |
| 108 | CDK12 | 0.58857895 |
| 109 | PRKCH | 0.58199801 |
| 110 | MAP3K7 | 0.57957466 |
| 111 | RIPK1 | 0.57841126 |
| 112 | MAPK4 | 0.57302789 |
| 113 | MKNK2 | 0.57288486 |
| 114 | RPS6KA5 | 0.55485877 |
| 115 | GRK7 | 0.52605117 |
| 116 | PDK1 | 0.52553564 |
| 117 | CSNK1G2 | 0.52038766 |
| 118 | EPHA4 | 0.50959387 |
| 119 | MATK | 0.50475887 |
| 120 | MAP3K8 | 0.49039817 |
| 121 | PRKCZ | 0.48296897 |
| 122 | PRKACA | 0.48254695 |
| 123 | PRKG2 | 0.46705057 |
| 124 | PAK3 | 0.45756690 |
| 125 | NEK2 | 0.45705093 |
| 126 | RAF1 | 0.44718542 |
| 127 | EPHA3 | 0.44337878 |
| 128 | MAP2K2 | 0.44224654 |
| 129 | MAP2K6 | 0.44043113 |
| 130 | HIPK2 | 0.43569598 |
| 131 | MAPK11 | 0.43317044 |
| 132 | PRKAA1 | 0.43088616 |
| 133 | NEK9 | 0.42856639 |
| 134 | CDK6 | 0.40849160 |
| 135 | TRPM7 | 0.40108569 |
| 136 | TIE1 | 0.40043295 |
| 137 | PRKCA | 0.39774821 |
| 138 | TNK2 | 0.39716367 |
| 139 | RPS6KA6 | 0.39209059 |
| 140 | FYN | 0.38802267 |
| 141 | EIF2AK3 | 0.38469398 |
| 142 | TAF1 | 0.38073068 |
| 143 | SIK3 | 0.37873904 |
| 144 | ABL1 | 0.37860863 |
| 145 | CAMK1 | 0.37833648 |
| 146 | CAMK4 | 0.36980146 |
| 147 | PRKCD | 0.36946883 |
| 148 | PRKACG | 0.36615864 |
| 149 | TAOK1 | 0.36485315 |
| 150 | MUSK | 0.36377773 |
| 151 | PKN1 | 0.35960464 |
| 152 | DMPK | 0.34529622 |
| 153 | CAMK1D | 0.33909309 |
| 154 | MAP3K3 | 0.33494064 |
| 155 | MAPKAPK2 | 0.33439164 |
| 156 | PHKG1 | 0.33361124 |
| 157 | PHKG2 | 0.33361124 |
| 158 | EGFR | 0.32763339 |
| 159 | RPS6KC1 | 0.32232245 |
| 160 | RPS6KL1 | 0.32232245 |
| 161 | NME1 | 0.32108981 |
| 162 | IGF1R | 0.31637535 |
| 163 | MAPKAPK3 | 0.31405638 |
| 164 | CSNK1A1 | 0.30797005 |
| 165 | MAP2K1 | 0.30351741 |
| 166 | CAMK2B | 0.30278539 |
| 167 | PRKAA2 | 0.29870517 |
| 168 | DYRK3 | 0.29645446 |
| 169 | ALK | 0.28228780 |
| 170 | OBSCN | 0.27444383 |
| 171 | FRK | 0.26960824 |
| 172 | NUAK1 | 0.26035041 |
| 173 | MELK | 0.26007656 |
| 174 | ATR | 0.25881864 |
| 175 | STK38L | 0.25761003 |
| 176 | FGFR2 | 0.25700052 |
| 177 | MAPK3 | 0.23778345 |
| 178 | SCYL2 | 0.23666264 |
| 179 | MAP3K5 | 0.20798454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.57457694 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.06862167 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.92332926 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.89022530 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77372216 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71998315 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.55421547 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.53828059 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53379638 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51518710 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47578796 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45537868 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.43062933 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.32421073 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.31524000 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22937090 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22532651 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20793723 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.16755973 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.15902324 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.01630674 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00486257 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.98523777 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88444844 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.88222213 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85255942 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84612444 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80326664 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78129645 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.76354783 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73786139 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.72568464 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71808734 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70358656 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68565395 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66855959 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.64489492 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.62837025 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.62821345 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.62324759 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.62079205 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.60437848 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60153287 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57812428 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57197548 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57099028 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.56184777 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.54774954 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51568018 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.51447987 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48770002 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.47081617 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45106954 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.44885438 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 1.44427832 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44295998 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.42753994 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.38795678 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36873710 |
| 60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31193849 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 1.31029213 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30559691 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.30374405 |
| 64 | Taste transduction_Homo sapiens_hsa04742 | 1.29255018 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.28404650 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26603158 |
| 67 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26420957 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 1.25830555 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23258350 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 1.19722329 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18613303 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18333262 |
| 73 | Malaria_Homo sapiens_hsa05144 | 1.18227315 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17402724 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14880176 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12693723 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.11468885 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.08311097 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05935757 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05664593 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04623518 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 1.04294508 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04261569 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 1.02862386 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 1.00949343 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00856096 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00572485 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.99971022 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.93772666 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93637647 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91419208 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90218431 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88918810 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87262276 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85645246 |
| 96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83245310 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81782901 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81389940 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.80977536 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79050636 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78879595 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77945390 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76950302 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76190228 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74174851 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73912716 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72998992 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72109364 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72103844 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71322429 |
| 111 | DNA replication_Homo sapiens_hsa03030 | 0.71220828 |
| 112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70946005 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69619325 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69216994 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.68379478 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67645500 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66111759 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65012713 |
| 119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64980001 |
| 120 | Protein export_Homo sapiens_hsa03060 | 0.64722445 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64367925 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63809272 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63299926 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63012277 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62950436 |
| 126 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62797696 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62761337 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62331068 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61972081 |
| 130 | Base excision repair_Homo sapiens_hsa03410 | 0.61801810 |
| 131 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61729520 |
| 132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60973877 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.60843482 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.60501208 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60165757 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58445315 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56744145 |
| 138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55632561 |
| 139 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55307784 |
| 140 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55287022 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53273463 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52529952 |
| 143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50270158 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50174129 |
| 145 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50157914 |
| 146 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49492262 |
| 147 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49065442 |
| 148 | Long-term depression_Homo sapiens_hsa04730 | 0.48972270 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47932446 |
| 150 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46533997 |
| 151 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46142194 |
| 152 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45126391 |
| 153 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44522534 |
| 154 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44507768 |
| 155 | ABC transporters_Homo sapiens_hsa02010 | 0.43878475 |
| 156 | Renin secretion_Homo sapiens_hsa04924 | 0.43298654 |
| 157 | Ribosome_Homo sapiens_hsa03010 | 0.42998701 |
| 158 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42532835 |
| 159 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42200795 |
| 160 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39484466 |
| 161 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38944825 |
| 162 | Homologous recombination_Homo sapiens_hsa03440 | 0.38386992 |
| 163 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37957888 |
| 164 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36113448 |
| 165 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35600817 |
| 166 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33649826 |
| 167 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32573897 |
| 168 | Axon guidance_Homo sapiens_hsa04360 | 0.32189978 |
| 169 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31228480 |
| 170 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31221631 |
| 171 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30652608 |
| 172 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30345178 |
| 173 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30008703 |
| 174 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29564683 |
| 175 | Phagosome_Homo sapiens_hsa04145 | 0.29489323 |
| 176 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28770566 |
| 177 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28119259 |
| 178 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27824356 |
| 179 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27416412 |
| 180 | Lysine degradation_Homo sapiens_hsa00310 | 0.27145781 |
| 181 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25780851 |
| 182 | Amoebiasis_Homo sapiens_hsa05146 | 0.24568878 |
| 183 | Mismatch repair_Homo sapiens_hsa03430 | 0.24128604 |
| 184 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22957729 |
| 185 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22030560 |

